• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

添加植物固醇的联合他汀类药物和考来维仑盐酸盐治疗未能降低低密度脂蛋白胆固醇浓度。

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.

机构信息

Department of Clinical Pharmacy, University of Colorado-Denver, 12631 East 17th Ave, PO Box 6511, Aurora, CO 80045, USA.

出版信息

J Clin Lipidol. 2007 Dec;1(6):626-33. doi: 10.1016/j.jacl.2007.10.004. Epub 2007 Oct 18.

DOI:10.1016/j.jacl.2007.10.004
PMID:21291705
Abstract

BACKGROUND

The purpose of this study was to evaluate the effects on LDL-cholesterol (LDL-C) from addition of plant sterol treatment to patients with dyslipidemia already taking a statin and colesevelam hydrochloride (HCl). Current cholesterol treatment guidelines recommend use of plant stanols/sterols to help reach LDL-C goals in patients taking other lipid-lowering therapies. Previous data demonstrate LDL-C lowering by adding stanols/sterols to statins. However, data are conflicting regarding the benefit from combination stanols/sterols with bile acid sequestrants.

METHODS

Fifty-five subjects on a stable dose of statin completed a 10-week, double-blind, randomized study of colesevelam HCl 3.75 g/day alone for 4 weeks, then 6 weeks of additional 2 g/day plant sterol-fortified orange juice (S-OJ) or placebo orange juice (P-OJ). Serum total cholesterol (TC), LDL-C, HDL-cholesterol (HDL-C), triglycerides (TG), apolipoprotein B (ApoB), and high-sensitivity C-reactive protein (hs-CRP) were measured at baseline, 4 weeks, and 10 weeks.

RESULTS

Baseline LDL-C measurements (mean ± SD) were similar between S-OJ and P-OJ groups (122 ± 20 vs 126 ± 24 mg/dL, respectively). Four weeks of colesevelam HCl in combination with a statin significantly reduced TC, LDL-C, and ApoB (9.6%, P < 0.001; 21.9%, P < 0.001; and 8.5%, P = 0.001, respectively), and significantly increased HDL-C (6.2%, P = 0.002) and TG (18.8%, P = 0.002). However, compared to P-OJ, 10 weeks of S-OJ produced no effect on any outcome parameter beyond that of colesevelam HCl.

CONCLUSION

Plant S-OJ appears to be ineffective at further reducing LDL-C when added to statin and colesevelam HCl combination therapy in patients with dyslipidemia.

摘要

背景

本研究旨在评估在服用他汀类药物和考来烯胺盐酸盐(HCl)的血脂异常患者中添加植物固醇治疗对 LDL-胆固醇(LDL-C)的影响。目前的胆固醇治疗指南建议使用植物甾醇/固醇来帮助服用其他降脂疗法的患者达到 LDL-C 目标。先前的数据表明,添加甾醇/固醇可降低 LDL-C。然而,关于组合使用甾醇/固醇与胆汁酸螯合剂的益处,数据存在矛盾。

方法

55 名服用稳定剂量他汀类药物的受试者完成了一项为期 10 周、双盲、随机研究,在第 4 周单独服用考来烯胺 HCl 3.75g/天,然后在第 6 周服用 2g/天强化植物固醇的橙汁(S-OJ)或安慰剂橙汁(P-OJ)。在基线、4 周和 10 周时测量血清总胆固醇(TC)、LDL-C、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、载脂蛋白 B(ApoB)和高敏 C 反应蛋白(hs-CRP)。

结果

S-OJ 和 P-OJ 组的基线 LDL-C 测量值(平均值±标准差)相似(分别为 122±20 和 126±24mg/dL)。他汀类药物联合考来烯胺 HCl 治疗 4 周可显著降低 TC、LDL-C 和 ApoB(分别降低 9.6%,P<0.001;降低 21.9%,P<0.001;降低 8.5%,P=0.001),并显著升高 HDL-C(升高 6.2%,P=0.002)和 TG(升高 18.8%,P=0.002)。然而,与 P-OJ 相比,S-OJ 在 10 周时的添加对除考来烯胺 HCl 以外的任何结果参数均无影响。

结论

当添加到他汀类药物和考来烯胺 HCl 联合治疗血脂异常患者时,植物 S-OJ 似乎无法进一步降低 LDL-C。

相似文献

1
Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.添加植物固醇的联合他汀类药物和考来维仑盐酸盐治疗未能降低低密度脂蛋白胆固醇浓度。
J Clin Lipidol. 2007 Dec;1(6):626-33. doi: 10.1016/j.jacl.2007.10.004. Epub 2007 Oct 18.
2
Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.盐酸考来维仑在高胆固醇血症患者中与他汀类药物联用时对低密度脂蛋白胆固醇和高敏C反应蛋白的影响。
Am J Cardiol. 2006 Apr 15;97(8):1198-205. doi: 10.1016/j.amjcard.2005.11.039. Epub 2006 Mar 3.
3
Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.盐酸考来维仑与依折麦布联合使用的降脂效果。
Curr Med Res Opin. 2006 Nov;22(11):2191-200. doi: 10.1185/030079906X148436.
4
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.考来烯胺联合他汀类药物和依折麦布治疗家族性高胆固醇血症患者:一项为期 12 周、多中心、随机、双盲、对照试验。
Clin Ther. 2010 Apr;32(4):615-25. doi: 10.1016/j.clinthera.2010.04.014.
5
Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.依折麦布与盐酸考来维仑联合用药和单独使用依折麦布对高胆固醇血症患者脂蛋白的影响:一项初步研究。
Metabolism. 2006 Dec;55(12):1697-703. doi: 10.1016/j.metabol.2006.08.013.
6
Add-on therapy for hypercholesterolemia: a pilot comparison of two gastrointestinally-acting agents in statin-treated patients.添加治疗高胆固醇血症:两种胃肠作用药物在他汀类药物治疗患者中的初步比较。
J Clin Lipidol. 2009 Apr;3(2):119-24. doi: 10.1016/j.jacl.2009.02.008. Epub 2009 Feb 11.
7
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.在老年患者中,依折麦布联合他汀类药物持续治疗对改善血脂谱及实现低密度脂蛋白胆固醇目标的有效性:一项随机、双盲、安慰剂对照试验数据的亚组分析
Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.
8
One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.瑞舒伐他汀联合非诺贝特治疗混合性血脂异常患者的一年疗效和安全性:剂量反应评估。
Am J Cardiovasc Drugs. 2012 Apr 1;12(2):117-25. doi: 10.2165/11597940-000000000-00000.
9
Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease.在动脉粥样硬化疾病患者中,添加烟酸缓释剂和考来维仑与他汀类药物联合治疗对血脂水平的影响。
J Clin Lipidol. 2007 Dec;1(6):620-5. doi: 10.1016/j.jacl.2007.09.001. Epub 2007 Sep 15.
10
Effects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemia.盐酸考来维仑(WelChol)对轻度高胆固醇血症患者炎症生物标志物的影响。
Am J Cardiol. 2006 Sep 1;98(5):641-3. doi: 10.1016/j.amjcard.2006.03.043. Epub 2006 Jul 7.

引用本文的文献

1
Dietary plant stanol ester supplementation reduces peripheral symptoms in a mouse model of Niemann-Pick type C1 disease.膳食植物甾烷醇酯补充剂可减轻尼曼-匹克 C1 型疾病小鼠模型的外周症状。
J Lipid Res. 2020 Jun;61(6):830-839. doi: 10.1194/jlr.RA120000632. Epub 2020 Apr 14.
2
Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.针对家族性高胆固醇血症的饮食干预措施(植物甾醇、甾烷醇、ω-3脂肪酸、大豆蛋白和膳食纤维)。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD001918. doi: 10.1002/14651858.CD001918.pub3.
3
Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action.
盐酸考来维仑:用于治疗高胆固醇血症和2型糖尿病的证据及作用机制洞察
Core Evid. 2012;7:61-75. doi: 10.2147/CE.S26725. Epub 2012 Jul 12.
4
A review of the rationale for additional therapeutic interventions to attain lower LDL-C when statin therapy is not enough.当他汀类药物治疗不足时,回顾一下增加治疗干预以降低 LDL-C 的基本原理。
Curr Atheroscler Rep. 2012 Feb;14(1):33-40. doi: 10.1007/s11883-011-0222-z.